SUNPHARMA.NS : Summary for SUN PHARMACEUTICAL INR1(DEMAT) - Yahoo Finance

U.S. Markets closed

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)


NSE - NSE Delayed Price. Currency in INR
Add to watchlist
679.65+4.15 (+0.61%)
At close: 3:29PM IST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close675.50
Open678.00
Bid0.00 x
Ask0.00 x
Day's Range672.50 - 686.40
52 Week Range571.90 - 898.45
Volume4,597,889
Avg. Volume3,919,669
Market Cap1.64T
BetaN/A
PE Ratio (TTM)22.15
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters6 days ago

    Sun Pharma's profits drop as U.S. sales hit by pricing, supply issues

    Sun Pharmaceutical Industries , India's largest drugmaker, reported its first fall in quarterly profits in a year on Tuesday, as pricing issues and supply constraints affected sales in the United States, its largest market. Sun's U.S. business faces increasing uncertainty as it struggles to fix quality control problems found by regulators at its key drug factories, and is the subject of a U.S. Department of Justice investigation into increases in drug prices.

  • Reuters7 days ago

    India's Sun Pharma Q3 profit falls nearly 5 pct; below estimates

    India's largest drugmaker Sun Pharmaceutical Industries Ltd's third-quarter profit fell below analysts' estimates due to slower sales in the United States, its largest market. Sun's net profit for the ...

  • Bloomberg28 days ago

    Document Shredding at Night Raises FDA Eyebrows During India Visit

    One Indian pharmaceutical firm’s nighttime document-shredding and potential manufacturing lapses at two others since December are reigniting concerns that, despite recent efforts, the country’s generic-drug ...